September 10, 2015 9:02am

Scleroderma therapy benefits sustained at one year follow-up. CYTX is UP +$0.09 or +22.25% to a wholesome $0.50 after closing up +$0.03 to $0.41. The share pricing is transitory but, BUY


Members only. Please login.